OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
600691$2.7358

Shanxi LuAn Chemical Technology Co Ltd

Diversified ChemicalsVerified

Capital Structure and Liquidity Shanxi LuAn Chemical Technology Co Ltd has a market capitalization of 6.49 billion CNY and a price-to-book ratio of 2.06, indicating a premium valuation relative to its book value. The company's liquidity position is characterized as medium, with a current ratio of 0.63, suggesting limited short-term liquidity to cover immediate liabilities. The debt-to-equity ratio of 2.58 highlights a significant reliance on debt financing, which could pose a risk in a rising interest rate environment. ### Profitability and Returns The company reported a net loss of 825.30 million CNY and an operating loss of 890.99 million CNY, reflecting a challenging operating environment. Return on equity (ROE) is negative at -26.16%, and return on assets (ROA) is also negative at -5.43%, indicating poor capital efficiency and asset utilization. These metrics fall significantly below the industry median for diversified chemicals, which typically exhibit positive ROE and ROA figures. ### Segments and Geographic Exposure The company operates as a single business segment, with no disclosed geographic diversification. This lack of segmentation and geographic spread increases exposure to regional economic and regulatory risks. ### Growth Trajectory The company's revenue for the latest period was 9.85 billion CNY, but the operating and net losses suggest a contraction in profitability. Analysts have issued one "buy" recommendation and no "strong buy" or "sell" ratings, indicating a cautious outlook. The company's free cash flow is negative at -1.14 billion CNY, and capital expenditures of -712.54 million CNY suggest ongoing investment in operations, though this is not offsetting the cash outflows from operations. ### Risk Factors The company faces medium liquidity risk due to a current ratio below 1 and a negative net cash position after subtracting total debt. The risk of dilution is assessed as low, with no near-term pressure from share issuance or convertible instruments. The debt-to-equity ratio of 2.58 also signals credit risk, particularly if interest rates rise or the company's operating performance does not improve. ### Recent Events Recent financial filings show a continued decline in profitability, with a net loss and operating loss in the latest reporting period. Analysts have not issued strong buy or sell recommendations, reflecting a neutral stance on the company's near-term prospects.

30-day price · 600691-0.56 (-16.8%)
Low$2.71High$3.51Close$2.78As of25 May, 00:00 UTC
Profile
CompanyShanxi LuAn Chemical Technology Co Ltd
Ticker600691.SS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Shanxi LuAn Chemical Technology Co Ltd is a diversified chemicals company engaged in the production and sale of chemical products, primarily serving industrial and manufacturing sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Diversified Chemicals industry with a confidence level of 0.92.

### Capital Structure and Liquidity Shanxi LuAn Chemical Technology Co Ltd has a market capitalization of 6.49 billion CNY and a price-to-book ratio of 2.06, indicating a premium valuation relative to its book value. The company's liquidity position is characterized as medium, with a current ratio of 0.63, suggesting limited short-term liquidity to cover immediate liabilities. The debt-to-equity ratio of 2.58 highlights a significant reliance on debt financing, which could pose a risk in a rising interest rate environment. ### Profitability and Returns The company reported a net loss of 825.30 million CNY and an operating loss of 890.99 million CNY, reflecting a challenging operating environment. Return on equity (ROE) is negative at -26.16%, and return on assets (ROA) is also negative at -5.43%, indicating poor capital efficiency and asset utilization. These metrics fall significantly below the industry median for diversified chemicals, which typically exhibit positive ROE and ROA figures. ### Segments and Geographic Exposure The company operates as a single business segment, with no disclosed geographic diversification. This lack of segmentation and geographic spread increases exposure to regional economic and regulatory risks. ### Growth Trajectory The company's revenue for the latest period was 9.85 billion CNY, but the operating and net losses suggest a contraction in profitability. Analysts have issued one "buy" recommendation and no "strong buy" or "sell" ratings, indicating a cautious outlook. The company's free cash flow is negative at -1.14 billion CNY, and capital expenditures of -712.54 million CNY suggest ongoing investment in operations, though this is not offsetting the cash outflows from operations. ### Risk Factors The company faces medium liquidity risk due to a current ratio below 1 and a negative net cash position after subtracting total debt. The risk of dilution is assessed as low, with no near-term pressure from share issuance or convertible instruments. The debt-to-equity ratio of 2.58 also signals credit risk, particularly if interest rates rise or the company's operating performance does not improve. ### Recent Events Recent financial filings show a continued decline in profitability, with a net loss and operating loss in the latest reporting period. Analysts have not issued strong buy or sell recommendations, reflecting a neutral stance on the company's near-term prospects.
Key takeaways
  • The company is operating at a net loss with a negative return on equity and assets, indicating poor profitability.
  • A debt-to-equity ratio of 2.58 suggests a high reliance on debt, increasing financial risk.
  • The company has a medium liquidity risk and a current ratio below 1, indicating limited short-term liquidity.
  • Analysts have issued one "buy" recommendation and no "strong buy" or "sell" ratings, reflecting a cautious outlook.
  • The company's free cash flow is negative, and capital expenditures are not offsetting the cash outflows from operations.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$9.85B
Gross profit$273.9M
Operating income-$891.0M
Net income-$825.3M
R&D
SG&A
D&A
SBC
Operating cash flow$596.9M
CapEx-$712.5M
Free cash flow-$1.14B
Total assets$15.21B
Total liabilities$12.05B
Total equity$3.16B
Cash & equivalents
Long-term debt$8.14B
Valuation
Market price$2.73
Market cap$6.49B
Enterprise value$14.63B
P/E
Reported non-GAAP P/E
EV/Revenue1.5
EV/Op income
EV/OCF24.5
P/B2.1
P/Tangible book2.1
Tangible book$3.16B
Net cash-$8.14B
Current ratio0.6
Debt/Equity2.6
ROA-5.4%
ROE-26.2%
Cash conversion-72.0%
CapEx/Revenue-7.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Diversified Chemicals · cohort 83 companies
Metric600691Activity
Op margin-9.0%6.3% medp25 2.1% · p75 9.6%bottom quartile
Net margin-8.4%3.3% medp25 0.2% · p75 6.4%bottom quartile
Gross margin2.8%23.5% medp25 13.2% · p75 31.9%bottom quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-7.2%-5.5% medp25 -11.2% · p75 -3.8%below median
Debt / equity258.0%42.1% medp25 16.7% · p75 82.4%top quartile
Observations
IR observations
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Last actual EPS-0.35 CNY
Last actual revenue9,840,969,580 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-25 05:27 UTC#c663458e
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 00:36 UTCJob: 4af77efb